Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Top Cited Papers
- 1 September 2020
- journal article
- editorial
- Published by Elsevier BV in Gastroenterology
- Vol. 159 (3), 1129-+
- https://doi.org/10.1053/j.gastro.2020.05.053
Abstract
No abstract availableFunding Information
- National Institutes of Health
This publication has 5 references indexed in Scilit:
- Existing bitter medicines for fighting 2019‐nCoV‐associated infectious diseasesThe FASEB Journal, 2020
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methodsActa Pharmaceutica Sinica. B, 2020
- Bone Marrow Myeloid Cells Regulate Myeloid-Biased Hematopoietic Stem Cells via a Histamine-Dependent Feedback LoopCell Stem Cell, 2017
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- The effect of histamine type 2 receptor antagonists on human immunodeficiency virus (HIV) replication: Identification of a new class of antiviral agentsLife Sciences, 1996